Prostate cancer Treatment's hidden cost: study tracks sexual side effects

NCT ID NCT07460726

Not yet recruiting Symptom relief Sponsor: CancerCare Manitoba Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 130 men with unfavorable intermediate-risk prostate cancer to see how a combination of targeted radiation (SBRT) and 6 months of hormone therapy (ADT) impacts their sexual function. Researchers measure erectile function before treatment and again after 24 months using a standard questionnaire. The goal is to better understand and manage sexual side effects, helping men make informed treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma erectile dysfunction physiological sexual disorder prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ERECTILE ABNORMALITIES PROSTATE CANCER (ADENOCARCINOMA) SEXUAL DYSFUNCTION MALE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Manitoba Prostate Centre

Winnipeg, Manitoba, R3E 0V9, Canada

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••